SEC Form 4 · accession 0001453687-19-000011
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Takashi Kei Kishimoto
Officer — Chief Scientific Officer
Period of report
Jan 7, 2019
Accepted (ET)
Jan 8, 2019 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.60 | Jan 7, 2019 | A | 100,000 | A | — | Jan 6, 2029 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1This option will vest as to 25% on January 7, 2020. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.